Literature DB >> 4316325

Carbenicillin treatment of Pseudomonas pulmonary infection. Use in children with cystic fibrosis.

J P Phair, J S Tan, C Watanakunakorn, L Schwab, L W Sanders.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4316325     DOI： 10.1001/archpedi.1970.02100060056006

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  6 in total

Review 1.  Dental caries prevalence in children and adolescents with cystic fibrosis: a qualitative systematic review and recommendations for future research.

Authors:  Donald L Chi
Journal:  Int J Paediatr Dent       Date:  2013-06-12       Impact factor: 3.455

Review 2.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1971-06       Impact factor: 2.401

3.  Comparison of the in vitro activity of BL-P1654 with gentamicin and carbenicillin against Pseudomonas aeruginosa.

Authors:  C Watanakunakorn; T Bannister
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

4.  Comparison of gentamicin, carbenicillin and gentamicin, and carbenicillin in Pseudomonas sepsis in monkeys.

Authors:  S Saslaw; H N Carlisle; M Moheimani
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

5.  Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.

Authors:  M R Hammerschlag; L Harding; A Macone; A L Smith; D A Goldmann
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

Review 6.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.